Showing results 1 - 1 of 1
September/October 2021, Paper: "On November 30, 2020, Moderna Therapeutics announced that Phase III clinical trials for its messenger RNA vaccine demonstrated 95%…
Stay updated on important insights with our free, weekly newsletter.